Literature DB >> 11508479

Translation, cultural adaptation, and initial reliability and multitrait testing of the Kidney Disease Quality of Life instrument for use in Japan.

J Green1, S Fukuhara, T Shinzato, Y Miura, S Wada, R D Hays, R Tabata, H Otsuka, I Takai, K Maeda, K Kurokawa.   

Abstract

BACKGROUND: The Kidney Disease Quality of Life instrument (KDQOL) consists of 79 items: 36 asking about health-related quality of life (HRQOL) in general (the Medical Outcomes Study SF-36) and 43 asking about QOL as it is affected by kidney disease and by dialysis. AIM: Translation, cultural adaptation and initial reliability and multitrait testing of the KDQOL for use in Japan.
METHODS: Translation and cultural adaptation began with two translations into Japanese, two backtranslations into English, and discussions among the translators, the project coordinators in Japan, and the developers of the original (US-English) version. Focus-group discussions and field testing were followed by analyses of test-retest reliability, internal consistency, and convergent and discriminant construct validity.
RESULTS: All eight of the SF-36 scales met the criterion for internal consistency (Cronbach's alpha ranged from 0.73 to 0.92) and were reproducible (intraclass correlations between test and retest scores ranged from 0.60 to 0.82). Of the 10 kidney-disease-targeted scales, only two had alpha coefficients of less than 0.70: 'sleep' (0.61) and 'quality of social interaction' (0.35). One item on the 'quality of social interaction' scale had a very weak correlation with the remainder of that scale (r = 0.10). Eliminating that item from scoring increased the alpha coefficient of the scale from 0.35 to 0.64. All three items on the 'quality of social interaction' scale had very strong correlations with other scales.
CONCLUSIONS: First, in Japanese patients receiving dialysis the SF-36 scales are internally consistent and their scores are reproducible. Second, with the possible exception of the 'quality of social interaction' scale, the Japanese version of the KDQOL, can provide psychometrically sound kidney-disease-targeted data on quality of life in such patients.

Entities:  

Mesh:

Year:  2001        PMID: 11508479     DOI: 10.1023/a:1016630825992

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  12 in total

1.  International Quality of Life Assessment (IQOLA) Project.

Authors:  N K Aaronson; C Acquadro; J Alonso; G Apolone; D Bucquet; M Bullinger; K Bungay; S Fukuhara; B Gandek; S Keller
Journal:  Qual Life Res       Date:  1992-10       Impact factor: 4.147

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan.

Authors:  S Fukuhara; S Bito; J Green; A Hsiao; K Kurokawa
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

4.  Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment.

Authors:  M Bullinger; J Alonso; G Apolone; A Leplège; M Sullivan; S Wood-Dauphinee; B Gandek; A Wagner; N Aaronson; P Bech; S Fukuhara; S Kaasa; J E Ware
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  [Validation of interviewer administration of the Short Form 36 Health Survey, and comparisons of health-related quality of life between community-dwelling and institutionalized elderly people].

Authors:  S Bito; S Fukuhara
Journal:  Nihon Ronen Igakkai Zasshi       Date:  1998-06

6.  Patient-based health status measures in outpatient dialysis. Early experiences in developing an outcomes assessment program.

Authors:  P S Kurtin; A R Davies; K B Meyer; J M DeGiacomo; M E Kantz
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

7.  Quantity of dialysis: quality of life--what is the relationship?

Authors:  A R Morton; C Meers; M A Singer; E B Toffelmire; W Hopman; J McComb; T A MacKenzie
Journal:  ASAIO J       Date:  1996 Sep-Oct       Impact factor: 2.872

8.  Monitoring dialysis patients' health status.

Authors:  K B Meyer; D M Espindle; J M DeGiacomo; C S Jenuleson; P S Kurtin; A R Davies
Journal:  Am J Kidney Dis       Date:  1994-08       Impact factor: 8.860

9.  Development of the kidney disease quality of life (KDQOL) instrument.

Authors:  R D Hays; J D Kallich; D L Mapes; S J Coons; W B Carter
Journal:  Qual Life Res       Date:  1994-10       Impact factor: 4.147

10.  Patients' perception of health on renal replacement therapy: evaluation using a new instrument.

Authors:  I H Khan; A M Garratt; A Kumar; D J Cody; G R Catto; N Edward; A M MacLeod
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

View more
  21 in total

1.  Determining the basic psychometric properties of the Greek KDQOL-SF.

Authors:  Nick Kontodimopoulos; Dimitris Niakas
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  Development and validation of a short-version checklist for patients undergoing hemodialysis based on the International Classification of Functioning, Disability and Health.

Authors:  Hideyo Tsutsui; Takayoshi Ohkubo; Yoshinari Tsuruta; Sawako Kato; Yoshinari Yasuda; Yoshiharu Oshida
Journal:  Clin Exp Nephrol       Date:  2014-12-28       Impact factor: 2.801

3.  Short-term outcome and quality of life in kidney transplant recipient with monoclonal gammopathy.

Authors:  Masaaki Yanishi; Hiroyasu Tsukaguchi; Takashi Yoshida; Hisanori Taniguchi; Kenji Yoshida; Takao Mishima; Yoshihiro Komai; Kaneki Yasuda; Masato Watanabe; Motohiko Sugi; Hidefumi Kinoshita; Tadashi Matsuda
Journal:  CEN Case Rep       Date:  2016-04-05

4.  Quality of life and protein-energy wasting in kidney transplant recipients.

Authors:  Akos Ujszaszi; Maria E Czira; Katalin Fornadi; Marta Novak; Istvan Mucsi; Miklos Z Molnar
Journal:  Int Urol Nephrol       Date:  2012-01-14       Impact factor: 2.370

5.  Fatigue is a predictor for cardiovascular outcomes in patients undergoing hemodialysis.

Authors:  Hidenori Koyama; Sanae Fukuda; Tetsuo Shoji; Masaaki Inaba; Yoshihiro Tsujimoto; Tsutomu Tabata; Senji Okuno; Tomoyuki Yamakawa; Shigeki Okada; Mikio Okamura; Hirohiko Kuratsune; Hisako Fujii; Yoshinobu Hirayama; Yasuyoshi Watanabe; Yoshiki Nishizawa
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

6.  Health-Related Quality of Life Sleep Score Predicts Transfer to Hemodialysis among Patients on Peritoneal Dialysis.

Authors:  Tomoki Nagasaka; Naoki Washida; Kiyotaka Uchiyama; Eriko Yoshida Hama; Ei Kusahana; Takashin Nakayama; Itaru Yasuda; Kohkichi Morimoto; Hiroshi Itoh
Journal:  Healthcare (Basel)       Date:  2022-06-01

7.  Cultural adaptation and validation of the "Kidney Disease and Quality of Life--Short Form (KDQOL-SF™) version 1.3" questionnaire in Egypt.

Authors:  Samar Abd ElHafeez; Sunny A Sallam; Zahira M Gad; Carmine Zoccali; Claudia Torino; Giovanni Tripepi; Hala S ElWakil; Noha M Awad
Journal:  BMC Nephrol       Date:  2012-12-13       Impact factor: 2.388

8.  Reliability and validity of the ESRD Symptom Checklist--Transplantation Module in Norwegian kidney transplant recipients.

Authors:  Knut Stavem; Rüdiger Ganss
Journal:  BMC Nephrol       Date:  2006-11-16       Impact factor: 2.388

9.  Effects of nutritional supplementation on fatigue, and autonomic and immune dysfunction in patients with end-stage renal disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  Sanae Fukuda; Hidenori Koyama; Kazuhiro Kondo; Hisako Fujii; Yoshinobu Hirayama; Tsutomu Tabata; Mikio Okamura; Tomoyuki Yamakawa; Shigeki Okada; Sumio Hirata; Hiroshi Kiyama; Osami Kajimoto; Yasuyoshi Watanabe; Masaaki Inaba; Yoshiki Nishizawa
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

Review 10.  Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review.

Authors:  Olalekan Lee Aiyegbusi; Derek Kyte; Paul Cockwell; Tom Marshall; Adrian Gheorghe; Thomas Keeley; Anita Slade; Melanie Calvert
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.